Valuation Colinz Laboratories Limited

Stocks

Market Closed - Bombay S.E. 18:02:33 24/09/2026 HKT			5-day change	1st Jan Change
75.00 ^INR	+1.49%		0.00%	+39.85%

08-20	Annjana Dugar, Likhitta Dugar and Antariksh Dugar completed the acquisition of an additional 0.000238% stake in Colinz Laboratories Limited for INR 324.	CI
07-30	Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	34.74	107.6	160	94.59	182.5	112.1
Change	-	209.87%	48.62%	-40.87%	92.92%	-38.57%
Enterprise Value (EV) ¹	-2.149	60.43	105.4	30.29	133.4	30.71
Change	-	2,911.96%	74.47%	-71.27%	340.39%	-76.98%
P/E	16.7x	31.8x	19.2x	19.5x	36.8x	21.8x
PBR	0.48x	1.4x	1.08x	1.06x	1.93x	1.12x
PEG	-	0.5x	0x	3.23x	17.76x	6.14x
Capitalization / Revenue	0.56x	1.54x	2.24x	1.35x	2.8x	1.83x
EV / Revenue	-0.03x	0.87x	1.47x	0.43x	2.04x	0.5x
EV / EBITDA	-0.65x	10.3x	16.7x	5.58x	26.9x	7.54x
EV / EBIT	-1.52x	15.7x	20.9x	7.34x	36.7x	12.2x
EV / FCF	-0.2x	8.87x	17.8x	4.12x	-7.62x	1.07x
FCF Yield	-506%	11.3%	5.62%	24.3%	-13.1%	93%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.4541	0.74	1.82	1.93	1.97	2.04
Distribution rate	-	-	-	-	-	-
Net sales ¹	61.59	69.74	71.55	70.3	65.28	61.36
EBITDA ¹	3.331	5.862	6.326	5.428	4.951	4.075
EBIT ¹	1.418	3.85	5.037	4.125	3.639	2.512
Net income ¹	2.076	3.393	4.574	4.867	4.966	5.145
Net Debt ¹	-36.89	-47.22	-54.55	-64.3	-49.09	-81.39
Reference price ²	7.60	23.55	35.00	37.55	72.44	44.50
Nbr of stocks (in thousands)	4,571	4,571	4,571	2,519	2,519	2,519
Announcement Date	30/8/21	24/8/22	29/8/23	29/8/24	28/8/25	20/8/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLINZ LABORATORIES LIMITED	-	-	-	-	1.94M
SUN PHARMACEUTICAL INDUSTRIES LTD.	34.41x	6.46x	22.39x	0.92%	46.71B
OTSUKA HOLDINGS CO., LTD.	15.9x	1.97x	8.74x	1.7%	36.9B
ZYDUS LIFESCIENCES LIMITED	28.06x	4x	16.57x	0.58%	12.18B
CIPLA LIMITED	26.92x	3.26x	16.91x	0.94%	11.66B
KRKA, D. D.	18.58x	3.37x	11.75x	3.79%	8.97B
GLENMARK PHARMACEUTICALS LIMITED	30.1x	3.94x	18.34x	0.15%	7.29B
GEDEON RICHTER	9.32x	2.15x	5.57x	4.76%	7.21B
ONO PHARMACEUTICAL CO., LTD.	15.18x	2.01x	6.67x	3.28%	7.09B
Average	22.31x	3.39x	13.37x	2.01%	15.34B
Weighted average by Cap.	24.71x	3.98x	15.17x	1.57%